Our History

 We never wanted to start a pharmaceutical research and development company, until it became apparent that a highly useful new cancer treatment would never see the light of day for patients otherwise. 

Our founder and Scientific Development Director, then a practicing academic surgeon, started researching safe and promising yet undeveloped potential cancer treatments in 1997, shortly after his own diagnosis with melanoma. In 2000, with his own cancer aggressively spreading despite the very best of standard treatment, he made himself the first test subject for a highly novel combination of two existing agents. The response was rapid and complete, and he remains profoundly thankful to have had no evidence of recurrent disease for many years. 

It wasn’t long until he started to be approached by a number of patients who had exhausted the benefit of standard cancer treatment without hope for ongoing improvement. While not every patient could be helped significantly, many were, and the success stories began to accumulate. 

After thirteen years of arduous work, a patent was finally obtained for the novel treatment technique in 2015, in the hopes that this would persuade an existing and well established research group to put the technique through the necessary rigorous clinical trial process and prove its worth. Despite some very serious attention from some of the nation’s largest pharmaceutical research institutes, no one ultimately elected to make the modest investment needed to develop it - and thus possibly diminish the profit potential of some of their much more expensive cancer treatment products.

The physician inventor who had seen his own life given back to him by this fairly simple treatment was determined not to see it fade away without helping as many as possible, and so in 2018 Precision Immunotherapeutics was founded. So far it has succeeded in increasing his workload and lowering his income even further.

But we are also succeeding in our mission, even without the larger corporate resources that would make the job so much easier and the process so much faster, and inching toward our goals of developing more effective, less toxic, and less expensive disease treatment options that are so widely needed. Because of that, we have zero doubt that the most exciting chapters of our history are yet to come.